Natco Pharma appoints Dr. Pavan Ganapati Bhat as Executive Director
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
He has over 25+ years of experience in the pharmaceutical Industry and has been working with the company for the past 6 years
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
Lupin is the 6th largest company in the Indian Pharmaceutical Market
he US FDA has issued six observations pursuant to the completion of the audit.
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
MINYM can be safely used by patients above 9 years of age.
Subscribe To Our Newsletter & Stay Updated